245 related articles for article (PubMed ID: 19741132)
1. Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila.
Ng CH; Mok SZ; Koh C; Ouyang X; Fivaz ML; Tan EK; Dawson VL; Dawson TM; Yu F; Lim KL
J Neurosci; 2009 Sep; 29(36):11257-62. PubMed ID: 19741132
[TBL] [Abstract][Full Text] [Related]
2. Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities.
Wang C; Lu R; Ouyang X; Ho MW; Chia W; Yu F; Lim KL
J Neurosci; 2007 Aug; 27(32):8563-70. PubMed ID: 17687034
[TBL] [Abstract][Full Text] [Related]
3. A Drosophila model for LRRK2-linked parkinsonism.
Liu Z; Wang X; Yu Y; Li X; Wang T; Jiang H; Ren Q; Jiao Y; Sawa A; Moran T; Ross CA; Montell C; Smith WW
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2693-8. PubMed ID: 18258746
[TBL] [Abstract][Full Text] [Related]
4. Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila.
Angeles DC; Ho P; Chua LL; Wang C; Yap YW; Ng C; Zhou Zd; Lim KL; Wszolek ZK; Wang HY; Tan EK
Hum Mol Genet; 2014 Jun; 23(12):3157-65. PubMed ID: 24459295
[TBL] [Abstract][Full Text] [Related]
5. LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.
Yao C; El Khoury R; Wang W; Byrd TA; Pehek EA; Thacker C; Zhu X; Smith MA; Wilson-Delfosse AL; Chen SG
Neurobiol Dis; 2010 Oct; 40(1):73-81. PubMed ID: 20382224
[TBL] [Abstract][Full Text] [Related]
6. The Drosophila hep pathway mediates Lrrk2-induced neurodegeneration.
Yang D; Thomas JM; Li T; Lee Y; Liu Z; Smith WW
Biochem Cell Biol; 2018 Aug; 96(4):441-449. PubMed ID: 29268033
[TBL] [Abstract][Full Text] [Related]
7. LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3ß.
Lin CH; Tsai PI; Wu RM; Chien CT
J Neurosci; 2010 Sep; 30(39):13138-49. PubMed ID: 20881132
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2.
Ramonet D; Daher JP; Lin BM; Stafa K; Kim J; Banerjee R; Westerlund M; Pletnikova O; Glauser L; Yang L; Liu Y; Swing DA; Beal MF; Troncoso JC; McCaffery JM; Jenkins NA; Copeland NG; Galter D; Thomas B; Lee MK; Dawson TM; Dawson VL; Moore DJ
PLoS One; 2011 Apr; 6(4):e18568. PubMed ID: 21494637
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity.
Lin CH; Lin HI; Chen ML; Lai TT; Cao LP; Farrer MJ; Wu RM; Chien CT
Hum Mol Genet; 2016 May; 25(10):1965-1978. PubMed ID: 26931464
[TBL] [Abstract][Full Text] [Related]
10. Dopamine neuron-specific LRRK2 G2019S effects on gene expression revealed by translatome profiling.
Pallos J; Jeng S; McWeeney S; Martin I
Neurobiol Dis; 2021 Jul; 155():105390. PubMed ID: 33984508
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.
Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ
Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749
[TBL] [Abstract][Full Text] [Related]
12. (G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse.
Chou JS; Chen CY; Chen YL; Weng YH; Yeh TH; Lu CS; Chang YM; Wang HL
Neurobiol Dis; 2014 Aug; 68():190-9. PubMed ID: 24830390
[TBL] [Abstract][Full Text] [Related]
13. AMP kinase activation mitigates dopaminergic dysfunction and mitochondrial abnormalities in Drosophila models of Parkinson's disease.
Ng CH; Guan MS; Koh C; Ouyang X; Yu F; Tan EK; O'Neill SP; Zhang X; Chung J; Lim KL
J Neurosci; 2012 Oct; 32(41):14311-7. PubMed ID: 23055502
[TBL] [Abstract][Full Text] [Related]
14. LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans.
Saha S; Guillily MD; Ferree A; Lanceta J; Chan D; Ghosh J; Hsu CH; Segal L; Raghavan K; Matsumoto K; Hisamoto N; Kuwahara T; Iwatsubo T; Moore L; Goldstein L; Cookson M; Wolozin B
J Neurosci; 2009 Jul; 29(29):9210-8. PubMed ID: 19625511
[TBL] [Abstract][Full Text] [Related]
15. UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2(G2019S) carriers and in vivo.
Mortiboys H; Furmston R; Bronstad G; Aasly J; Elliott C; Bandmann O
Neurology; 2015 Sep; 85(10):846-52. PubMed ID: 26253449
[TBL] [Abstract][Full Text] [Related]
16. Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson's disease mutant of Leucine-Rich Repeat Kinase 2 (LRRK2).
Linhart R; Wong SA; Cao J; Tran M; Huynh A; Ardrey C; Park JM; Hsu C; Taha S; Peterson R; Shea S; Kurian J; Venderova K
Mol Neurodegener; 2014 Jun; 9():23. PubMed ID: 24915984
[TBL] [Abstract][Full Text] [Related]
17. Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.
Smith WW; Pei Z; Jiang H; Moore DJ; Liang Y; West AB; Dawson VL; Dawson TM; Ross CA
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18676-81. PubMed ID: 16352719
[TBL] [Abstract][Full Text] [Related]
18. A dual inhibitor targeting HMG-CoA reductase and histone deacetylase mitigates neurite degeneration in
Lin CH; Lin HY; Fang JM; Chen CC
Aging (Albany NY); 2020 Nov; 12(24):25581-25598. PubMed ID: 33231564
[TBL] [Abstract][Full Text] [Related]
19. The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivo.
Cresto N; Gaillard MC; Gardier C; Gubinelli F; Diguet E; Bellet D; Legroux L; Mitja J; Auregan G; Guillermier M; Josephine C; Jan C; Dufour N; Joliot A; Hantraye P; Bonvento G; Déglon N; Bemelmans AP; Cambon K; Liot G; Brouillet E
Neurobiol Dis; 2020 Feb; 134():104614. PubMed ID: 31605779
[TBL] [Abstract][Full Text] [Related]
20. Identification of Targets from LRRK2 Rescue Phenotypes.
Toh J; Chua LL; Ho P; Sandanaraj E; Tang C; Wang H; Tan EK
Cells; 2021 Jan; 10(1):. PubMed ID: 33466414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
